Federal health regulators said late Friday that kid-size doses of Pfizer's COVID-19 vaccine appear highly effective at preventing symptomatic infections in elementary school children and caused no unexpected safety issues, as the U.S. weighs beginning ...
from Google Alert - health https://ift.tt/3E7TnD9
via IFTTT
0 comments:
Post a Comment